ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756355 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756355; 2) Community: the network communities that were significantly associated with the response to NSC 756355; 3) Molecule: the relationships between components within communities and NSC 756355; 4) MDR: the compounds that were significantly associated with the NSC 756355.

NSC Compound Enrichment Correlation
NSC 722985 Null 0.0131480612430041 -0.060571088
NSC 743432 2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione 0.0131480612430041 0.070358366
NSC 761769 Null 0.0152653588725063 -0.12599499
NSC 9706 Triethylenemelamine 0.0152653588725063 -0.020245942
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0152653588725064 -0.090267353
NSC 618296 Null 0.0152653588725064 -0.10651137
NSC 648365 Insulin-Methotrexate conjugate 0.0152653588725064 0.19024136
NSC 649677 Null 0.0152653588725064 -0.12729292
NSC 650931 2'-BROMO-4'-EPI-DAUNDRUBICIN 0.0152653588725064 0.053918501
NSC 676343 Null 0.0152653588725064 0.10858405
Total:49  Current:13    [First] [Prev] [Next] [Last]